Lipocine Withdraws Preliminary Injunction Threat Against Marketing of Clarus Therapeutics’ JATENZO® Product: Trial Date Set for ...
NORTHBROOK, Ill., Aug. 26, 2019 (GLOBE NEWSWIRE) -- Clarus today announced that Lipocine, Inc. has confirmed that it will not seek preliminary injunctive relief against Clarus in a lawsuit that asserts Clarus’s product JATENZO infringes certain Lipocine …